Published in J Asthma on March 01, 2006
Influence of current or former smoking on asthma management and control. Can Respir J (2008) 0.83
Self-regulation and women with asthma. Curr Opin Allergy Clin Immunol (2008) 0.83
Knowledge of actions of inhaled corticosteroids in patients who did not persist drug treatment early. Int J Clin Pharm (2012) 0.75
Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax (2012) 4.06
Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax (2013) 3.62
Adult Asthma Consensus Guidelines update 2003. Can Respir J (2004) 3.61
Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study. Can Respir J (2006) 3.27
Increased risk of childhood asthma from antibiotic use in early life. Chest (2007) 3.11
Bronchodilator use and the risk of arrhythmia in COPD: part 1: Saskatchewan cohort study. Chest (2012) 2.65
Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol (2003) 2.43
Should combination therapy with inhaled corticosteroids and long-acting beta2-agonists be prescribed as initial maintenance treatment for asthma? CMAJ (2002) 2.30
Fluoroquinolones and the risk of serious arrhythmia: a population-based study. Clin Infect Dis (2012) 2.17
Cardiovascular morbidity and mortality in COPD. Chest (2005) 2.01
Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med (2014) 2.00
Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med (2007) 1.85
A cohort study of traffic-related air pollution and mortality in Toronto, Ontario, Canada. Environ Health Perspect (2009) 1.77
Gender differences in survival following hospitalisation for COPD. Thorax (2010) 1.73
Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids. Ann Intern Med (2006) 1.71
The use of inhaled corticosteroids and the risk of adrenal insufficiency. Eur Respir J (2012) 1.67
Inhaled corticosteroids and the risks of diabetes onset and progression. Am J Med (2010) 1.66
Canadian Pediatric Asthma Consensus guidelines, 2003 (updated to December 2004): introduction. CMAJ (2005) 1.63
Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction. J Allergy Clin Immunol (2009) 1.52
Differences in airway remodeling between subjects with severe and moderate asthma. J Allergy Clin Immunol (2005) 1.52
Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case-control study. Chest (2010) 1.49
Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. J Allergy Clin Immunol (2006) 1.43
Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohort. Chest (2012) 1.42
Increased expression of ADAM33 and ADAM8 with disease progression in asthma. J Allergy Clin Immunol (2007) 1.40
The Ontario Asthma Regional Variation Study: emergency department visit rates and the relation to hospitalization rates. Chest (2006) 1.38
Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest (2007) 1.36
Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD. Can Respir J (2006) 1.32
Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis. Gut (2013) 1.26
Geographic and gender variability in the prevalence of bronchial responsiveness in Canada. Chest (2004) 1.26
CNODES: the Canadian Network for Observational Drug Effect Studies. Open Med (2012) 1.26
Asthma control in Canada: no improvement since we last looked in 1999. Can Fam Physician (2007) 1.24
Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study. Respir Med (2013) 1.19
Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma. J Allergy Clin Immunol (2009) 1.18
Childhood predictors of smoking in adolescence: a follow-up study of Montreal schoolchildren. CMAJ (2005) 1.16
Bias in observational study of the effectiveness of nasal corticosteroids in asthma. J Allergy Clin Immunol (2005) 1.14
Risks of pneumonia in patients with asthma taking inhaled corticosteroids. Am J Respir Crit Care Med (2010) 1.12
Implementation of a targeted screening program to detect airflow obstruction suggestive of chronic obstructive pulmonary disease within a presurgical screening clinic. Can Respir J (2015) 1.09
Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med (2003) 1.07
What do we know about asthma triggers? a review of the literature. J Asthma (2012) 1.06
T Cells localize with proliferating smooth muscle alpha-actin+ cell compartments in asthma. Am J Respir Crit Care Med (2010) 1.04
Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD. COPD (2012) 1.04
Variations and gaps in management of acute asthma in Ontario emergency departments. Chest (2008) 0.97
The coming of age of asthma guidelines. Lancet (2008) 0.96
The Asthma Quiz for Kidz: a validated tool to appreciate the level of asthma control in children. Can Respir J (2004) 0.96
The determinants of prevalence of health complaints among young competitive swimmers. Int Arch Occup Environ Health (2006) 0.96
Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study. Can Respir J (2003) 0.95
Assessment of a medication-based asthma index for population research. Am J Respir Crit Care Med (2002) 0.95
Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases. Am J Respir Crit Care Med (2010) 0.94
Oral corticosteroid use and the risk of acute myocardial infarction in chronic obstructive pulmonary disease. Can Respir J (2006) 0.93
Inhaled corticosteroid use in asthma and the prevention of myocardial infarction. Am J Med (2003) 0.91
The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database. Pharmacoepidemiol Drug Saf (2007) 0.90
TNF-alpha antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease. Pulm Pharmacol Ther (2007) 0.90
Diffuse panbronchiolitis in a Caucasian man in Canada. Can Respir J (2003) 0.89
Comparative efficacy of indacaterol in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2012) 0.89
Symposium on obesity and asthma - November 2, 2006. Can Respir J (2007) 0.89
Bronchodilator responsiveness and reported respiratory symptoms in an adult population. PLoS One (2013) 0.89
A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial. Anesthesiology (2012) 0.88
Profile of eicosanoids in breath condensate in asthma and COPD. J Breath Res (2012) 0.87
Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Arthritis Rheum (2006) 0.87
Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Chest (2003) 0.86
Effect of a web-based chronic disease management system on asthma control and health-related quality of life: study protocol for a randomized controlled trial. Trials (2011) 0.86
Airflow obstruction in young adults in Canada. Can Respir J (2007) 0.86
Discontinuation of Inhaled Corticosteroids in COPD and the Risk Reduction of Pneumonia. Chest (2015) 0.85
Patterns and determinants of compliance with inhaled steroids in adults with asthma. Can Respir J (2005) 0.85
Statins and the risk of interstitial lung disease: a cohort study. Thorax (2013) 0.84
Types, frequency and impact of asthma triggers on patients' lives: a quantitative study in five European countries. J Asthma (2013) 0.84
Hot tub lung mimicking classic acute and chronic hypersensitivity pneumonitis: two case reports. Can Respir J (2007) 0.84
Omalizumab for asthma: pharmacology and clinical profile. Expert Rev Respir Med (2009) 0.84
Psychologic distress and maladaptive coping styles in patients with severe vs moderate asthma. Chest (2010) 0.83
Randomised controlled trial for emphysema with a selective agonist of the γ-type retinoic acid receptor. Eur Respir J (2012) 0.83
Influence of current or former smoking on asthma management and control. Can Respir J (2008) 0.83
Increased glucocorticoid receptor-beta expression, but not decreased histone deacetylase 2, in severe asthma. J Allergy Clin Immunol (2006) 0.83
Development and validation of a predictive algorithm to identify adult asthmatics from medical services and pharmacy claims databases. Health Serv Res (2011) 0.83
Rates and patterns of chronic obstructive pulmonary disease exacerbations. Can Respir J (2004) 0.83
Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome? Treat Respir Med (2005) 0.83
Evaluating asthma control: a comparison of measures using an item response theory approach. J Asthma (2007) 0.83
Altitude-related hypoxia: risk assessment and management for passengers on commerical aircraft. Aviat Space Environ Med (2003) 0.82
Economic issues in the use of office spirometry for lung health assessment. Can Respir J (2003) 0.82
The value of early diagnosis for effective management of chronic obstructive pulmonary disease. J Fam Pract (2007) 0.82
Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease. CMAJ (2012) 0.82
The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. Respir Med (2008) 0.82
Dynamic airway evaluation with volume CT: initial experience. Can Assoc Radiol J (2010) 0.82
Asthma and allergic rhinitis in Quebec children. Can Respir J (2004) 0.81
Carbonic anhydrase inhibitors. Inhibition of the zinc and cobalt gamma-class enzyme from the archaeon Methanosarcina thermophila with anions. Bioorg Med Chem Lett (2004) 0.81
Risk of glaucoma in elderly patients treated with inhaled corticosteroids for chronic airflow obstruction. Pulm Pharmacol Ther (2009) 0.81
Evaluation of a questionnaire to assess compliance with anti-asthma medications. J Asthma (2004) 0.81
Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis. J Allergy Clin Immunol (2003) 0.81
Facilitators and solutions for practicing optimal guided asthma self-management: the physician perspective. Can Respir J (2013) 0.81
Correlates of quality of life in patients with asthma. Ann Allergy Asthma Immunol (2005) 0.81
Pesticide exposure and asthma. Am J Respir Crit Care Med (2002) 0.80
Parent-reported symptoms may not be adequate to define asthma control in children. Pediatr Pulmonol (2007) 0.80
Validation of The 30 Second Asthma Test as a measure of asthma control. Can Respir J (2007) 0.80
Tiotropium and simplified detection of dynamic hyperinflation. Chest (2007) 0.79
Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the methanoarchaeon Methanobacterium thermoautotrophicum (Cab) with anions. Bioorg Med Chem Lett (2004) 0.79
Infection with Mycoplasma pneumoniae is not related to asthma control, asthma severity, and location of airway obstruction. Int J Gen Med (2010) 0.79
Mortality among subjects with chronic obstructive pulmonary disease or asthma at two respiratory disease clinics in Ontario. Can Respir J (2011) 0.78